Kathryn Michelle Armstrong's most recent trade in Usana Health Sciences Inc was a trade of 1,165 Restricted Stock Units done . Disclosure was reported to the exchange on July 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc | Kathryn Michelle Armstrong | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2025 | 1,165 | 20,256 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | Kathryn Michelle Armstrong | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2025 | 1,165 | 1,165 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Kathryn Michelle Armstrong | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.95 per share. | 25 Jul 2025 | 517 | 648 (0%) | 0% | 31.9 | 16,518 | Common Stock |
| Usana Health Sciences Inc | Kathryn Michelle Armstrong | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 16,760 | 21,421 | - | - | Restricted Stock Units |